Search
Powered By HealthLine
Health Tools
 Mood Tracker
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Study: Leukemia Treatment Carries Risk of Breast Cancers

Ivanhoe Broadcast News


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Baby Steps: Fertility Findings
Tumor Detecting App: Medicine's Next Big Thing?
Powerful Combo Reducing Lymphedema
Fighting Breast Cancer on Your Lunch Break
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Detrol LA
Diflucan
Ditropan XL
More...

Related News Articles
 border=
Fewer U.S. Teens Having Babies, Binge Drinking: Report
Patient Disparities Seen in Lung Cancer Drug Trials
Satisfaction With Life Seems Good for the Heart
U.S. Database of Breast Cancer Treatment May Be Inaccurate
More...

(Ivanhoe Newswire) -- The Stat5a gene, known to spur the growth of some types of leukemia, may also play a significant role in the development of some breast cancers, according to researchers from Georgetown University Medical Center.

Does Stat5a play the 'good guy' or the 'bad guy'? Well, say the researchers, that all depends.

Text Continues Below



"Our studies [of] in vivo mouse models illustrate a dual role for the Stat5a protein in breast tissue," the study's lead author, Anne Miermont, MS, a doctoral student in tumor biology at Georgetown was quoted as saying. "While it can contribute to the growth of one type of precancerous lesion in the breast, this protein also appears to protect mammary cells from carcinogenic exposure."

The findings, presented at the annual meeting of the Endocrine Society in Washington, D.C., indicate this protein behaves differently in developing breast cancer cells, depending upon the estrogen receptor status. When estrogen receptor levels were positive, loss of Stat5a reduced development of breast cancer cells. However, when estrogen receptor levels were normal, loss of Stat5a not only had no effect on developing cancer cells, but it increased susceptibility to carcinogen-induced breast cancer.

The researchers emphasize that if the Stat5a protein is a target in the treatment of leukemia or other cancers, "it is important to fully understand how altering its function impacts the breast."

These findings need to be validated and expanded, say researchers, but they add, "this study underscores the need to fully understand the mechanisms that regulate its different roles in breast cells and how changes in Stat5a activity may affect different types of breast cancer generation."

SOURCE: 2009 Annual Meeting of the Endocrine Society in Washington, D.C.



If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 6/17/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2012. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire